MedTrace Logo

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

NCT02131207 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2017-12-21

No results posted yet for this study

Summary

This pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. This diagnostic procedure may aid in identifying lesions in the prostate which may have cancer. The lesions can then be targeted during the prostate biopsy to improve the accuracy of identifying prostate cancer.

Conditions

Interventions

DEVICE

magnetic resonance imaging

Undergo pelvic MRI

PROCEDURE

prostate biopsy

Undergo prostate biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Robert Abouassaly · Case Comprehensive Cancer Center

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-10
Primary Completion
2017-12-08
Completion
2017-12-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131207 on ClinicalTrials.gov